Last reviewed · How we verify

NCT06125613: pIPS/M1

Influence of Kinesiophobia on the Excitability of Connections Parieto-frontal During a Pointing Movement in Humans

Completed NA Last updated 17 January 2024
What this trial tests

NA trial testing Experimental in Kinesiophobia in 24 participants. Completed in 31 December 2023.

Timeline
10 December 2021
Primary endpoint
8 March 2023
31 December 2023

Quick facts

Lead sponsorUniversite du Littoral Cote d'Opale
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposebasic science
Enrollment24
Start date10 December 2021
Primary completion8 March 2023
Estimated completion31 December 2023
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Universite du Littoral Cote d'Opale

Who can join

Adults 18 to 65, any sex, with Kinesiophobia or Motor Coordination or Function; Developmental Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Objective(s) of the trial: Better understand the interaction between kinesiophobia and motor control. Main objective: To measure the influence of induced kinesiophobia on functional connectivity between the posterior parieto-occipital region and the primary motor cortex in healthy subjects during a pointing task. Secondary objectives: The secondary objectives will be 1) to verify the excitatory influence of pIPS stimulation on the excitability of M1 at rest and 2) to establish whether there is a correlation between functional connectivity and the level of kinesiophobia ( as measured by the Tampa Scale)

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Experimental

Trials testing the same drug.

Other recruiting trials for Kinesiophobia

Currently open trials in the same condition.

Other Universite du Littoral Cote d'Opale trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06125613.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing